Navigation Links
Researchers at LSTM part of the international team to sequence the tsetse genome
Date:4/25/2014

Researchers from LSTM are among those who have sequenced the genome of a species of tsetse fly (Glossina morsitans). The outcomes of this research will be invaluable to understanding more about the tsetse and other insect vector biology, knowledge which can be applied to improving the current vector control methods and may lead to more effective and affordable control strategies.

A paper summarising some of the findings will be published in the journal Science today, with more specific and in depth analyses of various aspects of tsetse biology being published as a collection of 10 papers within the PLOS family of journals.

The tsetse fly is the vector for African trypanosomiasis, a potentially fatal disease in people (sleeping sickness) and livestock (Nagana), throughout sub-Saharan Africa, with an estimated 70 million people at risk of infection. Unlike other disease vectors, such as mosquitoes and sandflies, both sexes of the tsetse fly feed exclusively on vertebrate blood, meaning that all tsetse are capable of spreading the disease. To deal with the nourishment issues arising from feeding exclusively on blood the tsetse has formed complex relationships with three different symbiotic bacteria. It is also unusual among insects as it gives birth to live young having evolved to lactate in order to provide nourishment to intrauterine offspring.

The work was carried out over a 10 year period following the formation of the International Glossina Genome Initiative in 2003. Around 146 scientists have contributed to the work, including members of the departments of Vector Biology, Parasitology and Clinical Sciences within LSTM, along with colleagues from around the world, with at least half of the contributors being from African institutions.

LSTM's Professor Mike Lehane was a member of the project leadership team and describes the significance of the work: "Human infections with African trypanosomes can be fatal if left untreated. It has not been possible to develop a vaccine for the disease due to the ability of trypanosomes to evade the mammalian immune system, this coupled with the fact that there are some significant side-effects and reports of growing resistance to current trypanocidal drug treatments means that vector control strategies remain the best hope to eliminate the disease.

"The work that has been carried out by such a large group of international researchers and scientists has not been without its challenges, but has given us detailed information on a wide range of aspects of tsetse biology. It has provided us with a vital research tool, which will be continually added to over time and may well lead to control strategies that can bring an end to suffering caused by the disease both in terms of the human cost as well as the economic losses due to affected livestock."


'/>"/>

Contact: Clare Bebb
c.bebb@liv.ac.uk
44-015-170-53135
Liverpool School of Tropical Medicine
Source:Eurekalert

Related medicine news :

1. Oxygen diminishes the hearts ability to regenerate, researchers discover
2. Finnish team of researchers finds a mutation in a tumor of the jaw
3. Depressed? Researchers identify new anti-depressant mechanisms, therapeutic approaches
4. Life stressors trigger neurological disorders, researchers find
5. Penn researchers find link between sleep and immune function in fruit flies
6. Penn Medicine researchers uncover hints of a novel mechanism behind general anesthetic action
7. CU researchers discover target for treating dengue fever
8. BUSM researchers find anti-seizure drug may reduce alcohol consumption
9. Researchers identify children with emotional behavior difficulties
10. Researchers identify similarities between HIV/AIDS and opioid addiction epidemics
11. Oxytocin, the love hormone, promotes group lying, according to Ben-Gurion U. researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... January 18, 2017 , ... The VA ... are collaborating on a research project focused on multiple sclerosis (MS). Led by ... use nanotechnology to control the disease without compromising normal immune function that often ...
(Date:1/18/2017)... ... 18, 2017 , ... The V Foundation for Cancer Research, a top-rated cancer ... and fundraising team, to compete in the Boston Marathon on April 17. From ... world’s oldest annual marathon to join Team V and support the Foundation’s mission to ...
(Date:1/18/2017)... ... 2017 , ... The Portee Insurance Agency, a family managed firm that offers ... and the DC region, is inaugurating a charity event aimed at fighting heart disease ... it the #1 killer in America. However, heart disease is largely preventable, and a ...
(Date:1/18/2017)... ... January 18, 2017 , ... Dr. Farhan Qureshi is an ... implants dentistry. His modern dental practice has two convenient office locations in Alexandria and ... Rated Dentist for the Alexandria area. This award confirms the fact that ...
(Date:1/18/2017)... ... January 18, 2017 , ... The Hear ... aid project with the donation of cochlear implants. In February 2017, the first ... thus a fair chance of leading an independent life. This engagement builds on ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... 2017 Precision medicine is an emerging ... of disease. The approach allows doctors and physicians ... The approach studies the individual profile at a ... In January 2015, Precision Medicine Initiative (PMI) was ... with more than one million volunteers. All of ...
(Date:1/17/2017)... -- Research and Markets has announced the addition of ... to their offering. ... The global artificial pancreas devices system market to grow at ... Artificial Pancreas Devices System Market 2016-2020, has been prepared based on ... covers the market landscape and its growth prospects over the coming ...
(Date:1/17/2017)... Jan. 17, 2017 The interventional radiology products ... 2021 from USD 6.35 billion in 2016, at a ... growth of this market are rising incidence of chronic ... invasive surgeries. The global interventional radiology products ... region. On the basis of type, the stents segment ...
Breaking Medicine Technology: